Zobrazeno 1 - 10
of 37
pro vyhledávání: '"A. J. Katin"'
Autor:
Michelle H. Braccioforte, Sharon Salenius, Anthony V. D'Amico, Ming-Hui Chen, R. Ross, Brian J. Moran, Daniel E. Doseretz, Michael J. Katin, Jing Wu, Brent S. Rose
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:778-784
Purpose The addition of androgen deprivation therapy (ADT) to radiation therapy (RT) is the standard of care for men with intermediate- and high-risk prostate cancer (PC). However, whether competing mortality (CM) affects the ability of ADT to improv
Autor:
Michael J. Katin, Brian J. Moran, Michelle H. Braccioforte, Anthony V. D'Amico, Ming-Hui Chen, Rudi Ross, Akash Nanda, Sharon Salenius, Daniel E. Dosoretz
Publikováno v:
European Urology. 65:177-185
Neoadjuvant hormone therapy (NHT) use is associated with an increased risk of all-cause mortality (ACM) in men with a history of coronary artery disease (CAD)-induced congestive heart failure (CHF) or myocardial infarction (MI). However, its effect i
Autor:
Michael J. Katin, Sharon Salenius, Daniel E. Dosoretz, Thomas J. Polascik, Anthony V. D'Amico, Kenneth D. Westover, Judd W. Moul, Ming-Hui Chen, Cary N. Robertson
Publikováno v:
BJU International. 110:1116-1121
Study Type – Therapy (retrospective cohort analysis) Level of Evidence 2b What's known on the subject? and What does the study add? Prostate cancer is generally considered to be high risk when the prostate-specific antigen (PSA) concentration is >2
Publikováno v:
Pharmacology Biochemistry and Behavior. 100:299-310
The responses of rats to intracranial injections of cholinergic drugs implicate acetylcholine in the control of male mating behavior and suggest specific brain areas as mediators of these effects. In particular, past work has linked the medial preopt
Autor:
Sharon Salenius, Karen M. Winkfield, Ming-Hui Chen, Daniel E. Dosoretz, Michael J. Katin, Rudi Ross, Anthony V. D'Amico
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 81:e345-e350
5068 Purpose: We investigated whether race was associated with risk of death following brachytherapy-based treatment for localized prostate cancer. Methods: The study cohort was comprised of 4,880 men with clinical stage T1–3N0M0 prostate cancer an
Autor:
Michael J. Katin, Samuel Z. Goldhaber, Rudi Ross, Sharon Salenius, Daniel E. Dosoretz, Anthony V. D'Amico, Ming-Hui Chen
Publikováno v:
Journal of Urology. 186:898-902
We investigated whether the decrease in death from cardiovascular disease, a major competing risk, explains the observed increase in prostate cancer specific mortality before 1992.Between 1991 and 2006, 1,880 men with known cardiovascular disease und
Autor:
Daniel E. Dosoretz, Rudi Ross, Michelle H. Braccioforte, Neil E. Martin, Paul L. Nguyen, Brian J. Moran, Sharon Salenius, Jim C. Hu, Michael J. Katin, Karen E. Hoffman, Toni K. Choueiri, Anthony V. D'Amico, Ming H. Chen, Philip W. Kantoff, Clair J. Beard
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 79:1318-1322
Background Brachytherapy for prostate cancer can be technically challenging in men with small prostates (≤20 cc), but it is unknown whether their outcomes are different than those of men with larger prostates. Methods and Materials We studied 6,416
Autor:
Sharon Salenius, Ming-Hui Chen, Michael J. Katin, Daniel E. Dosoretz, Michelle H. Braccioforte, Toni K. Choueiri, Brian J. Moran, Julia H. Hayes, Rudi Ross, Anthony V. D'Amico
Publikováno v:
BJU International. 106:979-985
Study Type – Prognosis (inception cohort) Level of Evidence 1b OBJECTIVE To examine the effect of short-course androgen-suppression therapy (AST) before brachytherapy on all-cause mortality (ACM) rates, stratified by the presence or absence of a hi
Autor:
Sharon Salenius, Anthony V. D'Amico, Michael J. Katin, Paul L. Nguyen, Rudi Ross, Samuel Z. Goldhaber, Ming H. Chen, Clair J. Beard, Neil E. Martin, Daniel E. Dosoretz
Publikováno v:
Cancer. 117:406-413
BACKGROUND: A study was undertaken to determine the impact of prior coronary revascularization (angioplasty, stent, or coronary artery bypass graft) on the risk of all-cause mortality after neoadjuvant hormonal therapy (HT) for prostate cancer (PC) i
Autor:
Ming-Hui Chen, Anthony V. D'Amico, Michael J. Katin, Akash Nanda, Lior Z. Braunstein, Sharon Salenius, Daniel E. Dosoretz
Publikováno v:
Clinical genitourinary cancer. 13(6)
The purpose of the study was to determine whether the extent of prostate radiotherapy (ie, whole-pelvic radiotherapy [WPRT] vs. prostate and seminal vesicle radiotherapy [PSVRT]) is associated with all-cause mortality (ACM) in men treated with or wit